Xenon Pharmaceuticals XENE
$37.04 −$0.52 (-1.38%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $37.04 0.00%
Open$37.22
Prev close$37.56
Day range$36.81 – $37.97
Volume1.09M
Market cap$3.64B
P/E (TTM)–
Dividend yield–
Analyst view
ConsensusBuy
Analysts14
Average target$73.40+98.2% vs. price
- Buy 100%
Low $60.00Now $37.04Avg $73.40High $90.00
Recent rating changes
The last 20 actions on file set price targets from $60.00 to $82.00, averaging $70.65.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 11 Nov 2026 | Wells Fargo | BUY | $64.00 |
| 10 Nov 2026 | Wells Fargo | BUY | $64.00 |
| 10 Nov 2026 | Evercore | BUY | $80.00 |
| 10 Nov 2026 | Needham | BUY | $60.00 |
| 10 Nov 2026 | H.C. Wainwright | BUY | $74.00 |
| 9 Nov 2026 | BofA Securities | BUY | $77.00 |
| 9 Nov 2026 | RBC Capital | BUY | $70.00 |
| 9 Nov 2026 | J.P. Morgan | BUY | – |
| 29 Oct 2026 | Wells Fargo | BUY | $64.00 |
| 29 Oct 2026 | Guggenheim | BUY | $73.00 |
| 29 Oct 2026 | H.C. Wainwright | BUY | $74.00 |
| 16 Oct 2026 | Wells Fargo | BUY | $64.00 |
| 12 Oct 2026 | BofA Securities | BUY | $77.00 |
| 5 Oct 2026 | Guggenheim | BUY | $73.00 |
| 1 Oct 2026 | RBC Capital | BUY | $70.00 |
| 21 Sep 2026 | Bloom Burton | BUY | $71.00 |
| 19 Sep 2026 | J.P. Morgan | BUY | $82.00 |
| 18 Sep 2026 | TD Cowen | BUY | – |
| 18 Sep 2026 | Wells Fargo | BUY | $64.00 |
| 18 Sep 2026 | William Blair | BUY | – |
No comments yet — be the first to weigh in on XENE.
Sign in to join the discussion.